Vanguard Group Inc Medicinova Inc Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Medicinova Inc stock. As of the latest transaction made, Vanguard Group Inc holds 623,574 shares of MNOV stock, worth $885,475. This represents 0.0% of its overall portfolio holdings.
Number of Shares
623,574
Previous 623,333
0.04%
Holding current value
$885,475
Previous $1.31 Million
30.43%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MNOV
# of Institutions
28Shares Held
5.1MCall Options Held
28.5KPut Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.57 Million0.47% of portfolio
-
Black Rock Inc. New York, NY695KShares$986,8190.0% of portfolio
-
Citigroup Inc592KShares$840,5780.0% of portfolio
-
Geode Capital Management, LLC Boston, MA527KShares$748,3380.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA250KShares$355,1630.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $69.6M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...